Global Biosurgery Market Overview
The global biosurgery market was valued at USD 14.83 billion in 2023, growing at a compound annual growth rate (CAGR) of 7.47% during the forecast period and expected to attain a value of USD 28.86 billion by 2032.Biosurgery is a branch of medical science that involves the use of biological materials, such as hemostats, sealants, adhesives, bone grafts, soft tissue patches and matrices, to enhance the healing process, prevent excessive bleeding, seal leaks and repair damaged tissues and bones. Biosurgery products are widely used in various surgical procedures, such as cardiovascular, orthopedic, neurosurgery, general surgery, gynecology, urology, and ophthalmology.
The global biosurgery market has been characterized by dynamic growth, driven by technological innovations, an aging global population, and an increase in the prevalence of chronic diseases that require surgical interventions. The market's expansion is also fueled by the growing demand for effective wound closure and surgical recovery solutions, which are critical for improving patient outcomes and reducing hospital stays.
Global Biosurgery Market Drivers and Constraints
The major factors driving the growth of the global biosurgery market are:
- The increasing prevalence of chronic diseases, such as diabetes, cancer, cardiovascular disorders, and osteoporosis, that require surgical interventions.
- The rising geriatric population and the associated increase in the incidence of age-related disorders, such as arthritis, cataract, and Alzheimer's.
- The growing demand for minimally invasive surgeries and the adoption of advanced technologies, such as robotics, nanotechnology, and bioprinting, that enhance the efficacy and safety of biosurgery products.
- The rising awareness and acceptance of biosurgery products among surgeons and patients, especially in emerging markets, such as China, India, Brazil, and South Africa.
- The increasing investments and funding by governments and private organizations in the research and development of biosurgery products.
The major factors restraining the growth of the global biosurgery market are:
- The high cost and low reimbursement of biosurgery products, especially in developing and underdeveloped countries.
- Stringent regulatory policies and approval processes for biosurgery products in various regions.
- The risk of adverse reactions, infections, and immune responses associated with the use of biosurgery products.
- The lack of skilled and trained professionals and the limited availability of biosurgery products in some regions.
Global Biosurgery Market Trends and Developments
The global biosurgery market is witnessing several trends and developments that are expected to shape its future growth and opportunities. Some of the key trends and developments are:- Technological Advancements: Innovations in biomaterials and surgical techniques are enhancing the effectiveness of biosurgery products. For example, the development of advanced hemostatic agents, sealants, and adhesives that offer better control of bleeding and improved wound healing is driving market growth.
- Growth in Minimally Invasive Surgeries: The increasing preference for minimally invasive surgeries (MIS) due to their advantages such as shorter hospital stays, less post-operative pain, and quicker recovery is boosting the demand for biosurgery products that are compatible with these procedures.
- Rising Prevalence of Chronic Diseases: The growing incidence of chronic diseases such as cancer, cardiovascular diseases, and obesity is leading to a higher number of surgical interventions, thereby fueling the demand for biosurgery products.
- Expansion in Emerging Markets: Emerging economies are witnessing a surge in healthcare expenditure, improved healthcare infrastructure, and a growing middle-class population. This is leading to increased adoption of advanced surgical procedures, including biosurgery, in these regions.
- Regenerative Medicine: The field of regenerative medicine is expanding, with an increasing number of applications for biosurgery products in tissue engineering, stem cell therapy, and organ transplantation. This is expected to drive further growth in the market.
- Stringent Regulatory Framework: The biosurgery market is subject to strict regulatory scrutiny, which can impact the approval and commercialization of new products. Companies are focusing on meeting regulatory standards to ensure market entry and acceptance.
- Collaborations and Acquisitions: Strategic collaborations, mergers, and acquisitions among key players are common in the biosurgery market. These alliances are aimed at expanding product portfolios, entering new markets, and leveraging technological expertise.
- Focus on Research and Development: Companies in the biosurgery market are investing heavily in research and development to innovate and develop new products that meet the evolving needs of the healthcare industry.
Global Biosurgery Market Segmentation
The global biosurgery market can be segmented based on product type, source, application, end-user and region.Market Breakup by Product Type
- Bone and Graft Substitutes
- Soft-Tissue Attachments
- Hemostatic Agents
- Surgical Sealants and Adhesives
- Adhesion Barriers
- Staple Line Reinforcement
Market Breakup by Source
- Biologics Products
- Synthetic Products
Market Breakup by Application
- Orthopedic Surgery
- General Surgery
- Neuro and1 Spine Surgery
- Cardiovascular Surgery
- Gynecological Surgery
- Other Applications
Market Breakup by End User
- Hospitals & Clinics
- Surgical Centres
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Biosurgery Market Competitive Landscape
The global biosurgery market is highly competitive and fragmented, with the presence of several key players and numerous local and regional players. Some of the major players operating in the market are Johnson & Johnson, Baxter International, Medtronic, BD, Integra Lifesciences, CSL, Sanofi, Atrium Medical, Cryolife, Hemostasis, Stryker, B. Braun, and Biom'up. These players are engaged in various strategies, such as mergers and acquisitions, product launches, collaborations, partnerships, and expansions, to gain a competitive edge and increase their market share.This product will be delivered within 5-7 business days.
Table of Contents
1 Preface
3 Global Biosurgery Market Overview
4 Global Biosurgery Market Landscape
5 Global Biosurgery Market Dynamics
6 Global Biosurgery Market Segmentation
7 North America Biosurgery Market
8 Europe Biosurgery Market
9 Asia Pacific Biosurgery Market
10 Latin America Biosurgery Market
11 Middle East and Africa Biosurgery Market
12 Patent Analysis
13 Grants Analysis
14 Funding Analysis
15 Partnership and Collaborations Analysis
16 Regulatory Framework
17 Supplier Landscape
18 Global Biosurgery Market - Distribution Model (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
21 Payment Methods (Additional Insight)
Companies Mentioned
- Baxter
- BD
- Johnson & Johnson Services Inc.
- Medtronic
- B. Braun Melsungen AG
- CryoLife Inc.
- Stryker Corporation
- Integra LifeSciences Corporation
- Hemostasis LLC
- CSL Limited
- AROA BIOSURGERY LIMITED
- TELA Bio Inc.
- Tissue Regenix
- Osiris Therapeutics Inc.
Methodology
LOADING...
